Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $568,027. The enterprise value is -$12.78 million.
| Market Cap | 568,027 |
| Enterprise Value | -12.78M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 193,866 shares outstanding. The number of shares has increased by 186.54% in one year.
| Current Share Class | 193,866 |
| Shares Outstanding | 193,866 |
| Shares Change (YoY) | +186.54% |
| Shares Change (QoQ) | +178.30% |
| Owned by Insiders (%) | 1.76% |
| Owned by Institutions (%) | 26.75% |
| Float | 144,992 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| Forward PS | 0.03 |
| PB Ratio | 0.01 |
| P/TBV Ratio | 0.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.46 |
| Quick Ratio | 3.21 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.92% and return on invested capital (ROIC) is -11.85%.
| Return on Equity (ROE) | -21.92% |
| Return on Assets (ROA) | -9.91% |
| Return on Invested Capital (ROIC) | -11.85% |
| Return on Capital Employed (ROCE) | -18.56% |
| Weighted Average Cost of Capital (WACC) | 5.33% |
| Revenue Per Employee | $706,935 |
| Profits Per Employee | -$116,653 |
| Employee Count | 50 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 1.96 |
Taxes
In the past 12 months, SBFM has paid $270,936 in taxes.
| Income Tax | 270,936 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.17% in the last 52 weeks. The beta is 1.35, so SBFM's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -99.17% |
| 50-Day Moving Average | 14.16 |
| 200-Day Moving Average | 109.05 |
| Relative Strength Index (RSI) | 27.32 |
| Average Volume (20 Days) | 896,622 |
Short Selling Information
| Short Interest | 840,899 |
| Short Previous Month | 131,478 |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, SBFM had revenue of $35.35 million and -$5.83 million in losses. Loss per share was -$163.91.
| Revenue | 35.35M |
| Gross Profit | 10.71M |
| Operating Income | -5.20M |
| Pretax Income | -5.56M |
| Net Income | -5.83M |
| EBITDA | -4.85M |
| EBIT | -5.20M |
| Loss Per Share | -$163.91 |
Balance Sheet
The company has $14.03 million in cash and $678,338 in debt, with a net cash position of $13.35 million or $68.87 per share.
| Cash & Cash Equivalents | 14.03M |
| Total Debt | 678,338 |
| Net Cash | 13.35M |
| Net Cash Per Share | $68.87 |
| Equity (Book Value) | 27.54M |
| Book Value Per Share | 230.48 |
| Working Capital | 25.05M |
Cash Flow
In the last 12 months, operating cash flow was -$5.35 million and capital expenditures -$19,145, giving a free cash flow of -$5.37 million.
| Operating Cash Flow | -5.35M |
| Capital Expenditures | -19,145 |
| Depreciation & Amortization | 349,667 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.37M |
| FCF Per Share | -$27.71 |
Margins
Gross margin is 30.30%, with operating and profit margins of -14.71% and -16.50%.
| Gross Margin | 30.30% |
| Operating Margin | -14.71% |
| Pretax Margin | -15.73% |
| Profit Margin | -16.50% |
| EBITDA Margin | -13.72% |
| EBIT Margin | -14.71% |
| FCF Margin | n/a |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -186.54% |
| Shareholder Yield | -186.54% |
| Earnings Yield | -5,594.13% |
| FCF Yield | -945.71% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 26, 2026. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
SBFM has an Altman Z-Score of -1.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.18 |
| Piotroski F-Score | 2 |